Sol-Gel Technologies (SLGL) Interest & Investment Income (2018)
Sol-Gel Technologies (SLGL) posted quarterly Interest & Investment Income of -$466000.0 for Q2 2018, down 1653.33% quarter-over-quarter from $30000.0 in Q1 2018.
Sol-Gel Technologies (SLGL) Interest & Investment Income (2018) Analysis & Trends
Sol-Gel Technologies (SLGL) has reported Interest & Investment Income for 1 consecutive years, with -$466000.0 the latest figure, recorded in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Sol-Gel Technologies | 240.26 Mn | 230.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1.09 Mn |
| Sep 30, 2018 | -652,000.00 |
| Jun 30, 2018 | -466,000.00 |
| Mar 31, 2018 | 30,000.00 |